Try our beta test site

Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

This study has been completed.
Immune Tolerance Network (ITN)
Information provided by:
Neurocrine Biosciences Identifier:
First received: March 8, 2004
Last updated: March 20, 2008
Last verified: September 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2005
  Primary Completion Date: No date given